secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avantor, Inc. (AVTR)
CIK:        0001722482
Form:       8-K
Filed at:   2021-11-02T23:59:59+00:00
Accession:  0001722482-21-000257
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avantor completes $900M term loan amendment to fund Curie acquisition; appoints Mala Murthy to board
--------------------------------------------------------------------------------

- Obtained $900M in incremental B-5 term loans at LIBOR+2.25% (0.50% floor), maturing Nov 2027.
- Proceeds used to fund acquisition of Curie Holdings, LLC and refinance existing Curie debt.
- Mala Murthy, CFO of Teladoc Health, appointed as Class I independent director effective Dec 1, 2021.
- Murthy to serve on Audit and Finance Committee; receives standard non-employee director compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1722482/000172248221000257/0001722482-21-000257-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1722482/000172248221000257/avtr-20211028.htm
  HTML page:      https://secwatch.observer/filing/0001722482-21-000257

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer